Sugammadex Injection, Solution
Product Images NDC 70748-370

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 70748-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 01)

Chemical structure of Sugammadex, showing its molecular framework with multiple hydroxyl groups and sodium carboxylate substituents forming a cyclic compound.*

FDA Label Image

Image (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 02)

Chemical structure of Sugammadex, showing the cyclic molecular arrangement with multiple hydroxyl groups, sodium carboxylate groups, and sulfur atoms, consistent with a modified cyclodextrin structure.*

FDA Label Image

Image (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 03)

A line chart depicting cumulative recovery rate versus time to recovery in minutes for Sugammadex, neostigmine, and Rocuronium plus Sugammadex at different dosages. The chart compares median recovery times and shows censored observations for the treatments over a 120-minute period.*

FDA Label Image

Image (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 04)

A cumulative recovery rate graph comparing recovery times over 120 minutes for Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg following Vecuronium use. The graph shows the percentage recovered on the Y-axis and time to recovery in minutes on the X-axis, with notable median recovery times displayed in an inset box.*

FDA Label Image

200 mg/2 mL Carton (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 05)

Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous injection solution vial label by Lupin Pharmaceuticals, Inc. The label shows product details, NDC 70748-370-02, and storage instructions. It includes manufacturing information, product origin (India), and vial count (10 single-dose 2 mL vials).*

FDA Label Image

500 mg/5 mL Carton (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 06)

The image shows a pharmaceutical carton label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) by Lupin Pharmaceuticals, Inc. The label states it is for intravenous use only, Rx only, and contains 10 single-dose 5 mL vials. Manufacturer information includes Lupin Limited, India, and Lupin Pharmaceuticals, Inc., United States.*

FDA Label Image

Image (F14c1fde 5fde 4b5d Afb9 7ba6059dcd57 143 1)

Sugammadex 100 mg/mL injection, solution vial label from Lupin Pharmaceuticals, Inc. The label features a white background with simple black text detailing the product name, strength, and dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.